 |
|
TREATMENT OF FUNGOUS INFECTIONS WITH ETHYL IODIDE INHALATIONSA REVIEW
JACOB H. SWARTZ, M.D.
Arch Derm Syphilol. 1939;40(6):962-973.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
The purpose of this paper is to bring up to date the subject of quantitative inhalation therapy in general, and ethyl iodide inhalation in particular. This paper contains data previously reported plus additional information gathered since the publication of the last paper on this subject. It deals with the following topics:
- General considerations
- Chemistry of ethyl iodide
- Fate of ethyl iodide in the body
- Amount of ethyl iodide retained in the body at the end of the inhalation period.
- Amount of ethyl iodide exhaled after the end of the inhalation period.
- Excretion of iodide in the urine.
- Clinical considerations
GENERAL CONSIDERATIONS
Iodide therapy has been used for years in cutaneous and systemic fungous infections. The usual methods of administration have been, first, oral and, later, intravenous. Quantitative inhalation therapy had not been reported previous to the publication by my associates and me of
. . . [Full Text PDF of this Article]
Author Affiliations
BOSTON
From the Departments of Dermatology, Beth Israel Hospital and Massachusetts General Hospital.
Footnotes
Read at the Sixty-Second Annual Meeting of the American Dermatological Association, Inc., Monte-Bello, Quebec, Canada, June 3, 1939.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
